| 000 | 01353 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518000817.0 | ||
| 264 | 0 | _c20181025 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1080/13543784.2018.1528225 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSepúlveda, Juan Manuel | |
| 245 | 0 | 0 |
_aDacomitinib: an investigational drug for the treatment of glioblastoma. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cOct 2018 |
||
| 300 |
_a823-829 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDrugs, Investigational _xpharmacology |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aQuinazolinones _xpharmacology |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aSánchez-Gómez, Pilar | |
| 700 | 1 | _aVaz Salgado, María Ángeles | |
| 700 | 1 | _aGargini, Ricardo | |
| 700 | 1 | _aBalañá, Carmen | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 27 _gno. 10 _gp. 823-829 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/13543784.2018.1528225 _zAvailable from publisher's website |
| 999 |
_c28867504 _d28867504 |
||